To conclude, miR-125b inhibition promotes neurite outgrowth but represses cell apoptosis and inflammation via blocking PTGS2 and CDK5 in a FOXQ1-dependent way in AD, which might provide the basis for developing potential drug targets for AD treatment. The gene discussed is CDK5; the disease is Alzheimer disease.